Evaluation of hyponatremia

Diseases

Summary

Hyponatremia is the most common electrolyte disorder encountered in clinical practice and is estimated to occur in up to 30% of hospital inpatients.[1] It is defined as a serum sodium <135 mEq/L (normal serum sodium concentration is in the range of 135 to 145 mEq/L); severe hyponatremia is defined as a serum sodium <125 mEq/L. Patients with hyponatremia have increased morbidity and mortality compared with patients without hyponatremia.[2][3] Mild hyponatremia is an independent risk factor for adverse outcome and mortality even in the general population.[4]

Hyponatremia is primarily a disorder of water balance. A low serum sodium concentration indicates dilute body fluids or an excess of water. The clinical manifestations of hyponatremia depend on the rate of decline of serum sodium. An acute fall in sodium over 24 to 48 hours produces severe cerebral edema, which can be fatal.[5] A gradual fall in sodium over several days or weeks can be compensated for by the brain, produces relatively modest morbidity and may be asymptomatic.[5]

In most cases, hyponatremia reflects hypotonicity or low effective osmolality. It is often iatrogenic and avoidable. Common causes of hyponatremia include true volume depletion, effective arterial volume depletion (e.g., congestive heart failure, cirrhosis), and medication-induced hyponatremia due to thiazide diuretics or antidepressants.[5] [6] [7]

Types of hyponatremia

Hyponatremia can result from a variety of conditions, based on different mechanisms, and can have multiple drivers. It may result from an inappropriate hypotonic fluid intake, inappropriate fluid retention by excessive antidiuretic hormone (ADH) which increases renal water reabsorption, or inadequate renal reabsorption of sodium.

Hyponatremia can be classified into 5 main types. The first three represent types of hypotonic, or true, hyponatremia and are further classified according to fluid volume status:

Hypovolemic hyponatremia (hypotonic): total body water decreases, but total body sodium decreases to a greater extent. The extracellular fluid volume is also decreased.
Euvolemic hyponatremia (hypotonic): total body water increases, but total body sodium remains unchanged. There is a modest increase in extracellular fluid volume, but not enough to cause edema.
Hypervolemic hyponatremia (hypotonic): total body water and sodium both increase, but total body water increases to a greater extent. The extracellular fluid volume is markedly increased, causing edema.
Hypertonic (redistributive) hyponatremia: increased osmotic pressure in the extracellular compartment causes water to shift from the intracellular to the extracellular compartment diluting extracellular sodium. However, total body sodium and water are unchanged. This is commonly seen with hyperglycemia and mannitol administration. This simple formula can be used to correct sodium level in the presence of hyperglycemia: serum sodium is decreased by 2.4 mEq/dL for every 100 mg/dL elevation of serum glucose over 100 mg/dL.
Pseudohyponatremia: excessive lipids or proteins dilute the aqueous phase of the extracellular compartment and the measured sodium levels are low. However, this decrease is an artifact and should be excluded before proceeding with further investigations. Total body sodium and water are unchanged, and there has not been a shift of fluid between compartments. The use of ion-specific electrodes has helped reduce the incidence of this artifact.[8]

Hyponatremia can also be classified according to its rate of onset.[2]

Acute hyponatremia is defined as hyponatremia with a duration of <48 hours.
Chronic hyponatremia is defined as hyponatremia with a duration of at least 48 hours. Chronic hyponatremia is much more common than acute, and cases where the duration of hyponatremia is unclear should be considered to be chronic unless there is clinical evidence suggesting otherwise.

Central nervous system effects of hyponatremia

Hyponatremia is significant when it is associated with a decline in extracellular osmolality, as it causes cellular edema. Most tissues can tolerate cellular edema, apart from the bony calvarium due to space limitations. Brain cells have long-term adaptive mechanisms that can compensate for low serum sodium and osmolality by giving up ions like potassium and synthesizing organic osmolytes to preserve cell volume. If the sodium concentration falls slowly over several days or weeks, the brain is able to use such mechanisms to adapt. For this reason, patients with chronic hyponatremia have relatively modest cerebral edema and do not develop brainstem herniation. However, if the sodium concentration falls rapidly over 24 to 48 hours, the compensatory mechanisms of the brain are overwhelmed and severe cerebral edema occurs, leading to brainstem herniation, respiratory arrest, and death. This can occur even with a modest fall in sodium (125-130 mEq/L).

Failure to correct hyponatremia can lead to permanent neurologic damage, as can correcting sodium levels too rapidly.[2] When hyponatremia is chronic and the serum sodium concentration increases too rapidly, osmotic demyelination syndrome (ODS; also known as central pontine myelinolysis) may develop. ODS is characterized by altered mental status, reduced motor functioning, and/or abnormalities of balance.[9] [10]

Library

Algorithm for the diagnosis of hypotonic hyponatremia. SIADH, syndrome of inappropriate antidiuretic hormone

Citations

Key Articles

Spasovski G, Vanholder R, Allolio B, et al; Hyponatraemia Guideline Development Group. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol. 2014 Feb 25;170(3):G1-47.[Abstract][Full Text]
Grant P, Ayuk J, Bouloux PM, et al. The diagnosis and management of inpatient hyponatraemia and SIADH. Eur J Clin Invest. 2015 Aug;45(8):888-94.[Abstract][Full Text]
Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013 Oct;126(10 suppl 1):S1-42.[Abstract][Full Text]

Other Online Resources

CAGE alcohol questionnaire

Referenced Articles

1. Adrogué HJ, Tucker BM, Madias NE. Diagnosis and management of hyponatremia: a review. JAMA. 2022 Jul 19;328(3):280-91.[Abstract]
2. Spasovski G, Vanholder R, Allolio B, et al; Hyponatraemia Guideline Development Group. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol. 2014 Feb 25;170(3):G1-47.[Abstract][Full Text]
3. Lien YH, Shapiro JI. Hyponatremia: clinical diagnosis and management. Am J Med. 2007 Aug;120(8):653-8.[Abstract]
4. Sajadieh A, Binici Z, Mouridsen MR, et al. Mild hyponatremia carries a poor prognosis in community subjects. Am J Med. 2009 Jul;122(7):679-86.[Abstract]
5. Wakil A, Ng JM, Atkin SL. Investigating hyponatraemia. BMJ. 2011 Mar 7;342:d1118.[Abstract]
6. Montanana PA, Modesto i Alapont V, Ocon AP, et al. The use of isotonic fluid as maintenance therapy prevents iatrogenic hyponatremia in pediatrics: a randomized, controlled open study. Pediatr Crit Care Med. 2008 Nov;9(6):589-97.[Abstract]
7. Grant P, Ayuk J, Bouloux PM, et al. The diagnosis and management of inpatient hyponatraemia and SIADH. Eur J Clin Invest. 2015 Aug;45(8):888-94.[Abstract][Full Text]
8. Lippi G, Aloe R. Hyponatremia and pseudohyponatremia: first, do no harm [letter]. Am J Med. 2010 Sep;123(9):e17.[Abstract][Full Text]
9. Lindner G, Schwarz C, Haidinger M, et al. Hyponatremia in the emergency department. Am J Emerg Med. 2022 Oct;60:1-8.[Abstract][Full Text]
10. Wang P, Li T. Osmotic demyelination syndrome: clinical and neuroimaging characteristics in a series of 8 cases. Quant Imaging Med Surg. 2023 Jul 1;13(7):4785-91.[Abstract][Full Text]
11. Sterns RH, Silver SM. Cerebral salt wasting versus SIADH: what difference? J Am Soc Nephrol. 2008 Feb;19(2):194-6.[Abstract][Full Text]
12. Loh JA, Verbalis JG. Disorders of water and salt metabolism associated with pituitary disease. Endocrinol Metab Clin North Am. 2008 Mar;37(1):213-34, x.[Abstract]
13. Lu DC, Binder DK, Chien B, et al. Cerebral salt wasting and elevated brain natriuretic peptide levels after traumatic brain injury: 2 case reports. Surg Neurol. 2008 Mar;69(3):226-9.[Abstract]
14. Filippone EJ, Ruzieh M, Foy A. Thiazide-associated hyponatremia: clinical manifestations and pathophysiology. Am J Kidney Dis. 2020 Feb;75(2):256-64.[Abstract][Full Text]
15. Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013 Oct;126(10 suppl 1):S1-42.[Abstract][Full Text]
16. Alukal JJ, John S, Thuluvath PJ. Hyponatremia in cirrhosis: an update. Am J Gastroenterol. 2020 Nov;115(11):1775-85.[Abstract]
17. Nagler EV, Vanmassenhove J, van der Veer SN, et al. Diagnosis and treatment of hyponatremia: a systematic review of clinical practice guidelines and consensus statements. BMC Med. 2014 Dec 11;12:1.[Abstract][Full Text]
18. Sterns RH. Disorders of plasma sodium - causes, consequences, and correction. N Engl J Med. 2015 Jan 1;372(1):55-65.[Abstract]
19. Kinugawa K, Sato N, Inomata T, et al. Efficacy and safety of tolvaptan in heart failure patients with volume overload. Circ J. 2014;78(4):844-52.[Abstract][Full Text]
20. Rushworth RL, Torpy DJ, Falhammar H. Adrenal crisis. N Engl J Med. 2019 Aug 29;381(9):852-61.[Abstract]
21. Kilpatrick ES. Disorders of sodium balance: hypothyroidism and hyponatraemia: an old wives' tale? BMJ. 2006 Apr 8;332(7545):854.
22. Liamis G, Filippatos TD, Liontos A, et al. Management of endocrine disease: hypothyroidism-associated hyponatremia: mechanisms, implications and treatment. Eur J Endocrinol. 2017 Jan;176(1):R15-R20.[Abstract]
23. Cuesta M, Ortolá A, Garrahy A, et al. Predictors of failure to respond to fluid restriction in SIAD in clinical practice; time to re-evaluate clinical guidelines? QJM. 2017 Aug 1;110(8):489-492.[Abstract][Full Text]
24. Cuesta M, Garrahy A, Slattery D, et al. The contribution of undiagnosed adrenal insufficiency to euvolaemic hyponatraemia: results of a large prospective single-centre study. Clin Endocrinol (Oxf). 2016 Dec;85(6):836-44.[Abstract]
25. Shapiro DS, Sonnenblick M, Galperin I, et al. Severe hyponatraemia in elderly hospitalized patients: prevalence, aetiology and outcome. Intern Med J. 2010 Aug;40(8):574-80.[Abstract]
26. Patel GP, Balk RA. Recognition and treatment of hyponatremia in acutely ill hospitalized patients. Clin Ther. 2007 Feb;29(2):211-29.[Abstract]
27. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2022 Apr 1;101161CIR0000000000001063.[Abstract][Full Text]
28. Braun MM, Barstow CH, Pyzocha NJ. Diagnosis and management of sodium disorders: hyponatremia and hypernatremia. Am Fam Physician. 2015 Mar 1;91(5):299-307.[Abstract][Full Text]
29. Simundic AM, Bölenius K, Cadamuro J, et al. Joint EFLM-COLABIOCLI recommendation for venous blood sampling. Clin Chem Lab Med. 2018;56(12):2015-38.[Abstract]
30. Webster J, Osborne S, Rickard CM, et al. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev. 2019 Jan 23;(1):CD007798.[Abstract][Full Text]
31. Leppäniemi A, Tolonen M, Tarasconi A, et al. 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg. 2019;14:27.[Abstract][Full Text]
32. American Society for Clinical Pathology. Choosing wisely: testing for amylase. Sep 2016 [internet publication].[Full Text]
33. Rompianesi G, Hann A, Komolafe O, et al. Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis. Cochrane Database Syst Rev. 2017 Apr 21;4:CD012010.[Abstract][Full Text]
34. Thomas ME, Blaine C, Dawnay A, et al. The definition of acute kidney injury and its use in practice. Kidney Int. 2015 Jan;87(1):62-73.[Abstract][Full Text]
35. National Institute for Health and Care Excellence. Acute kidney injury: prevention, detection and management. Oct 2024 [internet publication].[Full Text]